BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 18158502)

  • 41. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.
    Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA
    Clin Transpl; 2006; ():57-70. PubMed ID: 18368705
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits.
    Pucci M; Sarween N; Knox E; Lipkin G; Martin U
    Expert Rev Clin Pharmacol; 2015 Mar; 8(2):221-31. PubMed ID: 25612630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ACE inhibitors and major congenital malformations.
    Sealey JE; Itskovitz-Eldor J
    N Engl J Med; 2006 Sep; 355(12):1280-1; author reply 1281. PubMed ID: 16990393
    [No Abstract]   [Full Text] [Related]  

  • 44. An evaluation of data for 10 children born to mothers who attempted suicide by taking large doses of alprazolam during pregnancy.
    Gidai J; Acs N; Bánhidy F; Czeizel AE
    Toxicol Ind Health; 2008; 24(1-2):53-60. PubMed ID: 18818181
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Kidney insufficiency and persistent hypotension following compromise of the renin-angiotensin system in a fetus and a young infant].
    van Lieburg AF; Monnens LA
    Ned Tijdschr Geneeskd; 2001 Apr; 145(14):695-8. PubMed ID: 11530709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clonazepam use in pregnancy and the risk of malformations.
    Lin AE; Peller AJ; Westgate MN; Houde K; Franz A; Holmes LB
    Birth Defects Res A Clin Mol Teratol; 2004 Aug; 70(8):534-6. PubMed ID: 15329832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Periconceptional exposure to contraceptive pills and risk for Down syndrome.
    Martínez-Frías ML; Bermejo E; Rodríguez-Pinilla E; Prieto L
    J Perinatol; 2001; 21(5):288-92. PubMed ID: 11536021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: A nested case-control study.
    Ofori B; Oraichi D; Blais L; Rey E; Bérard A
    Birth Defects Res B Dev Reprod Toxicol; 2006 Aug; 77(4):268-79. PubMed ID: 16929547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
    Diav-Citrin O; Shechtman S; Halberstadt Y; Finkel-Pekarsky V; Wajnberg R; Arnon J; Di Gianantonio E; Clementi M; Ornoy A
    Reprod Toxicol; 2011 May; 31(4):540-5. PubMed ID: 21338666
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Behavioural changes induced by angiotensin-converting enzyme inhibition during pregnancy and lactation in adult offspring rats.
    Mecawi AS; Araujo IG; Fonseca FV; Almeida-Pereira G; Côrtes WS; Rocha FF; Reis LC
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):495-500. PubMed ID: 19673931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Paroxetine use during pregnancy: is it safe?
    Thormahlen GM
    Ann Pharmacother; 2006 Oct; 40(10):1834-7. PubMed ID: 16926304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study.
    Diav-Citrin O; Shechtman S; Gotteiner T; Arnon J; Ornoy A
    Teratology; 2001 May; 63(5):186-92. PubMed ID: 11320529
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ACE inhibitors and congenital anomalies.
    Friedman JM
    N Engl J Med; 2006 Jun; 354(23):2498-500. PubMed ID: 16760451
    [No Abstract]   [Full Text] [Related]  

  • 54. [Inhibition of the renin angiotensin system in pregnancy and risk of fetal malformations].
    Lonati C; Morganti A
    Pediatr Med Chir; 2009; 31(3):137-9. PubMed ID: 19739495
    [No Abstract]   [Full Text] [Related]  

  • 55. [ACE inhibitors should not be administered to pregnant women].
    Lakartidningen; 1992 May; 89(20):1814. PubMed ID: 1598045
    [No Abstract]   [Full Text] [Related]  

  • 56. Maternal occupational exposure to solvents and congenital malformations: a prospective study in the general population.
    Garlantézec R; Monfort C; Rouget F; Cordier S
    Occup Environ Med; 2009 Jul; 66(7):456-63. PubMed ID: 19541806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy.
    Einarson A; Pistelli A; DeSantis M; Malm H; Paulus WD; Panchaud A; Kennedy D; Einarson TR; Koren G
    Am J Psychiatry; 2008 Jun; 165(6):749-52. PubMed ID: 18381907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy.
    Hanssens M; Keirse MJ; Vankelecom F; Van Assche FA
    Obstet Gynecol; 1991 Jul; 78(1):128-35. PubMed ID: 2047053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exposure to nitrofurantoin during the first trimester of pregnancy and the risk for major malformations.
    Goldberg O; Koren G; Landau D; Lunenfeld E; Matok I; Levy A
    J Clin Pharmacol; 2013 Sep; 53(9):991-5. PubMed ID: 23873250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A study of the effects of large doses of medazepam used for self-poisoning in 10 pregnant women on fetal development.
    Gidai J; Acs N; Bánhidy F; Czeizel AE
    Toxicol Ind Health; 2008; 24(1-2):61-8. PubMed ID: 18818182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.